🇺🇸 FDA

Company profile · Sponsor

Sagimet

Sagimet Biosciences

SGMT · NYSE pharma SAN MATEO, CA, USA
Pipeline
12
Drugs
0
Patents
1

Quick answer

Sagimet (SGMT) is a pharma company. headquartered in SAN MATEO, CA, USA. listed on NYSE. NovaPharmaNews links 12 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker SGMT
Exchange NYSE
Company type pharma
Headquarters SAN MATEO, CA, USA
SEC CIK 0001400118

Pipeline (12)

Search pipeline →

  1. Denifanstat

    Sagimet

    MASH

    phase 3 small molecule terminated

    1 trial

  2. denifanstat

    Sagimet

    MASLD

    phase 3 small molecule terminated

    1 trial

  3. 3-V Bioscience-2640

    Sagimet

    Metabolic Syndrome

    phase 2 small molecule completed

    1 trial

  4. TVB-2640

    Sagimet

    Metabolic Dysfunction-assocated Steatohepatitis/ Nonalcoholic Fatty Liver Disease

    phase 2 small molecule completed

    1 trial

  5. TVB-2640

    Sagimet

    KRAS Gene Mutation

    phase 2 small molecule active

    1 trial

  6. TVB-2640 25 mg (US)

    Sagimet

    MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)

    phase 2 small molecule completed

    1 trial

  7. Denifanstat

    Sagimet

    Healthy

    phase 1 small molecule completed

    1 trial

  8. TVB-2640

    Sagimet

    Prostatic Neoplasms, Castration-Resistant

    phase 1 small molecule active

    1 trial

  9. TVB-2640

    Sagimet

    Solid Malignant Tumor

    phase 1 small molecule completed

    1 trial

  10. TVB-2640 - 50 mg

    Sagimet

    Non-alcoholic Steatohepatitis

    phase 1 small molecule completed

    1 trial

  11. TVB-3567

    Sagimet

    Acne

    phase 1 small molecule active

    1 trial

  12. [14C]-TVB-2640

    Sagimet

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial

Patents (1)

Search patents →

  1. US 11622968

    Heterocyclic modulators of lipid synthesis

    Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Sagimet?

Sagimet (SGMT) is a pharma company. headquartered in SAN MATEO, CA, USA. listed on NYSE. NovaPharmaNews links 12 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Sagimet sponsor?

We track 12 ClinicalTrials.gov-linked programs for Sagimet, including Denifanstat and 11 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Sagimet company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.